Bosutinib: Management of Adverse Events in Chronic Myeloid Leukemia

Managing adverse effects after starting a TKI can be challenging, and health care practitioners often look to CML experts for guidance.

from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2sL8IH2